Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Deulorlatinib |
Trade Name | |
Synonyms | TGRX-326|TGRX326|TGRX 326 |
Drug Descriptions |
Deulorlatinib (TGRX-326) is a third-generation ALK and ROS1 inhibitor, which potentially inhibits growth of ALK or ROS1-positive tumors (PMID: 39551469). |
DrugClasses | ALK Inhibitor 33 ROS1 Inhibitor 22 |
CAS Registry Number | 2131126-33-3 |
NCIT ID | C189066 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Deulorlatinib | Deulorlatinib | 4 | 0 |